Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer
Abstract Background Poly (ADP‐ribose) polymerase (PARP) inhibitors have been increasingly used in the treatment of ovarian cancer, with BRCA positivity and homologous recombination deficiency (HRD) being common biomarkers used for predicting their efficacy. However, given the limitations of these bi...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-04-01
|
| Serier: | Cancer Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/cam4.7149 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
